Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
Investors often chase certainty, but the loudest promises can hide fragile fundamentals. This guide shows how to spot...
Ukrainian strikes on energy assets push Russia into a fresh wave of fuel shortages. Households tighten belts as refin...
SpaceX surged on its IPO buzz, then cooled as investors weighed the risk and reward. This guide breaks down what a 30...
Micron stock retreats after a spring rally, renewing the debate over whether the memory chip maker has peaked. Analys...
A sudden political pivot put South Carolina in the spotlight as former President Trump floated Darline Graham Nordone...
Oil traders are watching a rumored china’s ‘secret’ billion barrel reserve as prices hold steady amid mixed Chinese i...
Tesla stands out as a founder led tech titan in a sea of transitions. This guide explains why elon musk's tesla remai...
Midsize U.S. firms reduced payments to Chinese suppliers in 2025 as tariff policy remained volatile, signaling a broa...
Amazon disclosed a record $200 billion capital expenditure plan for 2026, prompting investor questions about the time...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...